Skip to main content

Concord Medical Services Holdings Ltd

corporate_fare Company Profile

Concord Medical Services Holdings Ltd

CCM·NYSE·Industrial Applications And Services·CIK 0001472072

Concord Medical Services Holdings Ltd operates a network of cancer hospitals and cooperative centers in China. As of December 31, 2025, the company had eight cooperative centers located within six hospitals, spread across six cities in five provinces and administrative regions in China. These cooperative centers are a key part of the company's business model, with growth historically driven by new arrangements with hospital partners or acquisitions. In addition to its cooperative centers, Concord Medical Services Holdings Ltd is establishing its own cancer hospitals and clinics. As of December 31, 2025, the company had four self-owned cancer hospitals and clinics in operation in China. These include one comprehensive cancer hospital, two cancer diagnosis and treatment clinics, and one imaging diagnosis center. The company was also constructing Shanghai Hospital as of December 31, 2025. The expansion of both cooperative centers and self-owned facilities directly impacts patient visits and revenue growth. The range and mix of services provided, along with the cost of medical equipment, also affect the company's financial performance. New facilities typically experience a ramp-up period where operating efficiency may be lower than established ones.

Concord Medical Services Holdings Ltd (NYSE:CCM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 6 items for CCM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-22, rated 9/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for CCM spans 6-K, 20-F.

Recent high-impact activity:

  • Concord Medical to Restate 2024-2025 Financials After SEC Flags Loss of Control Over Key Subsidiary
  • Concord Medical Announces CFO Transition Amid Subsidiary Strategic Review
  • Concord Medical Faces Potential Deconsolidation of Key Subsidiary, Raising Financial Uncertainty
  • Subsidiary Concord Healthcare Completes HK$68M Convertible Bond Issue
  • Concord Healthcare Subsidiary Reports Executive Director Resignation Amidst Parent's Going Concern Warning

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
¥460.51M CNY
Net Income
-¥92.81M CNY
Diluted EPS
-¥0.71 CNY
Op. Cash Flow
-¥201.82M CNY
Free Cash Flow
-¥258.15M CNY
Gross Profit
¥25.82M CNY
Operating Income
-¥261.49M CNY
Cash & Equivalents
¥297.79M CNY
Total Debt
¥3.02B CNY
Debt / Equity
-1.43×
Net Margin
-20.2%
Shares Outstanding
130.25M sh
Source: 20-F · filed 2026-04-29 · accession 0001104659-26-050692

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 13,607 shares in CCM as of the September 15, 2026 settlement, a 24.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 79.4% of CCM volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)13,607 shares as of September 15, 2026
Change vs prior period▼ 24.8%
Days to cover1.00 at avg daily volume of 27,610
Daily short volume (FINRA facilities)79.4% of 5,030 shares on October 2, 2026
5-day average short volume34.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

CCM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with C →
$2.94
52-week range · as of 2026-09-22 $2.94 – $6.98
Market cap
$13.76M
Volume
8K (0.3× avg)
3-mo avg 29.1K
Live data · 2026-10-04 23:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CCM - Latest Insights

CCM
Sep 22, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.71
Real-time Price: $2.94 info
Change: -$0.770 (-21%) info
Market Cap: $13.763M info
CCM
Jul 02, 2026, 7:07 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.51
Real-time Price: $2.94 info
Change: -$1.57 (-35%) info
Market Cap: $13.763M info
CCM
May 18, 2026, 6:59 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $5.14
Real-time Price: $2.94 info
Change: -$2.20 (-43%) info
Market Cap: $13.763M info
CCM
May 13, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.35
Real-time Price: $2.94 info
Change: -$2.41 (-45%) info
Market Cap: $13.763M info
CCM
May 13, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $2.94 info
Change: -$2.36 (-45%) info
Market Cap: $13.763M info
CCM
Apr 29, 2026, 6:08 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $3.81
Real-time Price: $2.94 info
Change: -$0.870 (-23%) info
Market Cap: $13.763M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets